File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug

TitleA DFT study of Graphene as a drug carrier for gemcitabine anticancer drug
Authors
Keywordsdensity functional theory
drug delivery
gemcitabine
graphene
Issue Date31-Dec-2022
PublisherJournal of New Materials for Electrochemical Systems; 1999
Citation
Journal of New Materials for Electrochemical Systems, 2022, v. 25, n. 4, p. 234-239 How to Cite?
Abstract

Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design.


Persistent Identifierhttp://hdl.handle.net/10722/338883
ISSN
2023 Impact Factor: 0.7
2023 SCImago Journal Rankings: 0.230
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorAbahussain, AAM-
dc.contributor.authorZaidi, SZJ-
dc.contributor.authorNazir, MH-
dc.contributor.authorRaza, M-
dc.contributor.authorNazir, MH-
dc.contributor.authorHassan, S-
dc.date.accessioned2024-03-11T10:32:14Z-
dc.date.available2024-03-11T10:32:14Z-
dc.date.issued2022-12-31-
dc.identifier.citationJournal of New Materials for Electrochemical Systems, 2022, v. 25, n. 4, p. 234-239-
dc.identifier.issn1480-2422-
dc.identifier.urihttp://hdl.handle.net/10722/338883-
dc.description.abstract<p>Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design.</p>-
dc.languageeng-
dc.publisherJournal of New Materials for Electrochemical Systems; 1999-
dc.relation.ispartofJournal of New Materials for Electrochemical Systems-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectdensity functional theory-
dc.subjectdrug delivery-
dc.subjectgemcitabine-
dc.subjectgraphene-
dc.titleA DFT study of Graphene as a drug carrier for gemcitabine anticancer drug-
dc.typeArticle-
dc.identifier.doi10.14447/jnmes.v25i4.a02-
dc.identifier.scopuseid_2-s2.0-85146320921-
dc.identifier.volume25-
dc.identifier.issue4-
dc.identifier.spage234-
dc.identifier.epage239-
dc.identifier.isiWOS:000913381900002-
dc.identifier.issnl1480-2422-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats